| 000 | 01471 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250516103753.0 | ||
| 264 | 0 | _c20130516 | |
| 008 | 201305s 0 0 eng d | ||
| 022 | _a1179-2019 | ||
| 024 | 7 |
_a10.2165/11594740-000000000-00000 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarrett, David | |
| 245 | 0 | 0 |
_aTargeting the PI3K/AKT/mTOR signaling axis in children with hematologic malignancies. _h[electronic resource] |
| 260 |
_bPaediatric drugs _cOct 2012 |
||
| 300 |
_a299-316 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aHematologic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoproliferative Disorders _xdrug therapy |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xmetabolism |
| 650 | 0 | 4 | _aPhosphoinositide-3 Kinase Inhibitors |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xantagonists & inhibitors |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xantagonists & inhibitors |
| 700 | 1 | _aBrown, Valerie I | |
| 700 | 1 | _aGrupp, Stephan A | |
| 700 | 1 | _aTeachey, David T | |
| 773 | 0 |
_tPaediatric drugs _gvol. 14 _gno. 5 _gp. 299-316 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/11594740-000000000-00000 _zAvailable from publisher's website |
| 999 |
_c21985343 _d21985343 |
||